Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Aug 16, 2022

SELL
$255.51 - $362.11 $255 - $362
-1 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$351.38 - $448.68 $938,887 - $1.2 Million
-2,672 Reduced 99.96%
1 $0
Q3 2021

Nov 08, 2021

BUY
$372.64 - $458.3 $568,648 - $699,365
1,526 Added 133.04%
2,673 $1.1 Million
Q2 2021

Jul 29, 2021

BUY
$294.17 - $371.65 $62,952 - $79,533
214 Added 22.94%
1,147 $424,000
Q1 2021

May 06, 2021

BUY
$249.67 - $299.48 $232,942 - $279,414
933 New
933 $270,000
Q4 2020

Jan 29, 2021

SELL
$222.0 - $252.62 $362,526 - $412,528
-1,633 Closed
0 $0
Q3 2020

Oct 09, 2020

BUY
$175.56 - $226.45 $286,689 - $369,792
1,633 New
1,633 $370,000
Q4 2017

Feb 13, 2018

SELL
$100.43 - $118.09 $541,317 - $636,505
-5,390 Closed
0 $0
Q3 2017

Oct 11, 2017

BUY
$96.72 - $109.26 $521,320 - $588,911
5,390
5,390 $582,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Usa Financial Portformulas Corp Portfolio

Follow Usa Financial Portformulas Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

News

Stay updated on Usa Financial Portformulas Corp with notifications on news.